Paper Details

  1. Home
  2. Paper Details

Development and Content Validity Testing of a Patient-Reported Treatment Acceptance Measure for Use in Patients Receiving Treatment via Subcutaneous Injection.

Author: ArbuckleRob, GrantLaura, KhanIrfan, ManvelianGaren, SanchezRobert J, SpertusJohn A, TatlockSophi

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

The Injection-Treatment Acceptance Questionnaire (I-TAQ) was developed to assess patients' perspectives on treatment requiring subcutaneous injections. Qualitative interviews with 29 patients at high cardiovascular risk confirmed the I-TAQ's content validity.
Paper Details　
Original Abstract of the Article :
BACKGROUND: New therapies in development for lowering low-density lipoprotein cholesterol, such as alirocumab, require administration by subcutaneous injections. There is a need to assess the acceptance of such treatments and their mode of administration. OBJECTIVES: To develop a novel patient-repo...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.jval.2015.09.2937

データ提供：米国国立医学図書館（NLM）

Measuring Treatment Acceptance for Subcutaneous Injections

This study describes the development and content validity testing of a new patient-reported outcome measure, the Injection-Treatment Acceptance Questionnaire (I-TAQ). The I-TAQ was designed to assess patients' acceptance of treatments delivered via subcutaneous injections, such as those used for lowering low-density lipoprotein cholesterol.

Developing a New Instrument for Treatment Acceptance

The authors used qualitative methods to ensure that the I-TAQ captured the key concepts related to treatment acceptance. They conducted in-depth interviews with patients to understand their experiences and perspectives on subcutaneous injections. The I-TAQ was refined based on patient feedback to ensure its content validity.

Improving Patient-Centric Care

This research highlights the importance of understanding patients' perspectives on treatment options. The development of the I-TAQ provides a valuable tool for assessing treatment acceptance, which can inform clinical decision-making and improve patient-centered care.

Dr. Camel's Conclusion

The I-TAQ, like a well-worn trail in the desert, helps us understand how patients feel about receiving subcutaneous injections. This research underscores the importance of patient-centered care and the need for instruments that capture the patient's voice.

Date :
  1. Date Completed 2016-04-27
  2. Date Revised 2015-12-21
Further Info :

Pubmed ID

26686784

DOI: Digital Object Identifier

10.1016/j.jval.2015.09.2937

Related Literature

Article Analysis
・Side Effects of alirocumab injection
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.